Target intelligence / Profile preview

Programmed cell death 1 ligand 1 messenger RNA (CD274 mRNA)

Target
CD274 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

CD274 messenger RNA (mRNA) is the primary transcript of the CD274 gene, which encodes the Programmed cell death 1 ligand 1 (PD-L1) protein. PD-L1 is a critical transmembrane protein that functions as an immune checkpoint by binding to the PD-1 receptor on T cells, thereby inhibiting T-cell activation and promoting self-tolerance (Source: NCBI Gene, ID: 29126). In the context of oncology, many tumors overexpress CD274 mRNA to produce high levels of PD-L1 protein, allowing them to evade the host immune system (Source: PubMed, PMID: 30410170). While traditional immunotherapies utilize monoclonal antibodies to block the PD-L1 protein, targeting the CD274 mRNA itself using RNA interference (RNAi) or antisense oligonucleotides is an emerging therapeutic approach designed to prevent protein production at the source (Source: PubMed, PMID: 33230236). This strategy aims to achieve more complete silencing of the PD-L1 pathway and may be effective in patients who are resistant to protein-targeting agents.

Other names
PD-L1 mRNAB7-H1 mRNACD274 transcriptProgrammed death ligand 1 messenger RNA
02

Mechanism of action

RNA interference (RNAi) mediated degradation of mRNA, antisense oligonucleotide (ASO) mediated translational inhibition, or small molecule modulation of mRNA stability to prevent the synthesis of PD-L1 protein.

03

Biological functions

Protein translationImmune checkpoint regulationPost-transcriptional regulation
04

Disease associations

CancerImmune evasionChronic viral infectionAutoimmune disease
05

Safety considerations

Off-target silencing of unintended genesInnate immune activation via Toll-like receptors (TLRs)Delivery vehicle toxicity (e.g., lipid nanoparticle-associated inflammation)Systemic cytokine release
06

Interacting drugs

SRN-001

2 more in the full profile.

07

Biomarkers

CD274 mRNA expression level (via RT-qPCR or RNA-seq)PD-L1 mRNA In Situ Hybridization (ISH) score

Beyond the preview

Go deeper on Programmed cell death 1 ligand 1 messenger RNA (CD274 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Programmed cell death 1 ligand 1 messenger RNA (CD274 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call